- Report
- May 2025
- 196 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- February 2025
- 185 Pages
Global
From €3358EUR$3,825USD£2,881GBP
€3950EUR$4,500USD£3,390GBP
- Report
- May 2025
- 300 Pages
Global
From €3507EUR$3,995USD£3,009GBP
- Report
- May 2025
- 184 Pages
Global
From €3112EUR$3,545USD£2,670GBP
€3458EUR$3,939USD£2,967GBP
- Report
- August 2024
- 142 Pages
Global
From €2633EUR$2,999USD£2,259GBP
- Report
- November 2024
- 171 Pages
Global
From €5223EUR$5,950USD£4,482GBP
- Report
- June 2025
- 127 Pages
Global
From €5135EUR$5,850USD£4,407GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,382GBP
- Report
- April 2022
- 290 Pages
Global
From €3665EUR$4,175USD£3,145GBP
- Report
- April 2020
- 63 Pages
Global
- Report
- February 2024
- 117 Pages
Global
From €4170EUR$4,750USD£3,578GBP
- Report
- April 2023
- 115 Pages
Global
From €4170EUR$4,750USD£3,578GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more